A Perspective on Management of COPD Through the Lens of Comorbidities in the General and Elder Populations: Observations From the GOLDEN Studies
Friday, October 9, 2020 at 6:00pm Pacific (45 minutes)
  • COPD Disease Burden in the General Population vs Nursing Homes and Long-term Care
  • Phase III, GOLDEN studies on the efficacy and safety of Lonhala® Magnair® 
  • Post hoc analysis of primary data sets
Focus on Comorbidities
Clinically important deterioration
  • eFlow® Closed System (eFlow® CS) nebulizer 
  • Health Economic Perspective

Register Now

Shahin Sanjar PhD
Senior Director, Medical Affairs
Sunovion Pharmaceuticals Inc.
Sponsored by: